Detail akcie IM Cannabis Rg online

Business Summary: IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.
Financial Summary: BRIEF: For the three months ended 31 March 2024, IM Cannabis Corp revenues decreased 4% to C$12.1M. Net loss increased from C$600K to C$5.6M. Revenues reflect Israel segment decrease of 5% to C$10.9M. Higher net loss reflects Other operating expenses increase from C$0K to C$2.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -C$0.05 to -C$0.42.